163 related articles for article (PubMed ID: 32080836)
1. Chronic medical conditions and late effects following non-Hodgkin lymphoma in HIV-uninfected and HIV-infected adolescents and young adults: a population-based study.
Abrahão R; Li QW; Malogolowkin MH; Alvarez EM; Ribeiro RC; Wun T; Keegan THM
Br J Haematol; 2020 Aug; 190(3):371-384. PubMed ID: 32080836
[TBL] [Abstract][Full Text] [Related]
2. Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors.
Keegan THM; Li Q; Steele A; Alvarez EM; Brunson A; Flowers CR; Glaser SL; Wun T
Cancer Causes Control; 2018 Jun; 29(6):551-561. PubMed ID: 29654427
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study.
Keegan THM; Kushi LH; Li Q; Brunson A; Chawla X; Chew HK; Malogolowkin M; Wun T
J Cancer Surviv; 2018 Jun; 12(3):388-397. PubMed ID: 29427203
[TBL] [Abstract][Full Text] [Related]
4. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
[TBL] [Abstract][Full Text] [Related]
5. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
6. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
7. Chronic medical conditions and late effects after acute myeloid leukaemia in adolescents and young adults: a population-based study.
Abrahão R; Huynh JC; Benjamin DJ; Li QW; Winestone LE; Muffly L; Keegan THM
Int J Epidemiol; 2021 May; 50(2):663-674. PubMed ID: 34000732
[TBL] [Abstract][Full Text] [Related]
8. Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors.
Abrahão R; Brunson AM; Kahn JM; Li QW; Wun T; Keegan THM
Leuk Lymphoma; 2022 May; 63(5):1091-1101. PubMed ID: 34989283
[TBL] [Abstract][Full Text] [Related]
9. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
Abrahão R; Brunson A; Ruddy KJ; Li Q; Li J; Ryder MM; Chubak J; Nichols HB; Sauder CAM; Gray MF; Hahn EE; Wun T; Keegan THM
Br J Cancer; 2024 Apr; 130(7):1166-1175. PubMed ID: 38332179
[TBL] [Abstract][Full Text] [Related]
10. Chronic Comorbidities Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
J Clin Oncol; 2020 Sep; 38(27):3161-3174. PubMed ID: 32673152
[TBL] [Abstract][Full Text] [Related]
11. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
[TBL] [Abstract][Full Text] [Related]
12. Late new morbidity in survivors of adolescent and young-adulthood brain tumors in Finland: a registry-based study.
Gunn ME; Malila N; Lähdesmäki T; Arola M; Grönroos M; Matomäki J; Lähteenmäki PM
Neuro Oncol; 2015 Oct; 17(10):1412-8. PubMed ID: 26136494
[TBL] [Abstract][Full Text] [Related]
13. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
14. Late effects in survivors treated for lymphoma as adolescents and young adults: a population-based analysis.
Lo AC; Chen B; Samuel V; Savage KJ; Freeman C; Goddard K
J Cancer Surviv; 2021 Dec; 15(6):837-846. PubMed ID: 33453004
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin lymphoma among young adults with and without AIDS in Italy.
Dal Maso L; Rezza G; Zambon P; Tagliabue G; Crocetti E; Vercelli M; Zanetti R; Falcini F; Tonini G; Mangone L; De Lisi V; Ferretti S; Tumino R; Stanta G; Vitarelli S; Serraino D; Franceschi S;
Int J Cancer; 2001 Aug; 93(3):430-5. PubMed ID: 11433410
[TBL] [Abstract][Full Text] [Related]
16. Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma: a registry based study in Northern Germany.
Gebauer J; Fick EM; Waldmann A; Langer T; Kreitschmann-Andermahr I; Lehnert H; Katalinic A; Brabant G
Eur J Endocrinol; 2015 Aug; 173(2):139-48. PubMed ID: 25947143
[TBL] [Abstract][Full Text] [Related]
17. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
18. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.
Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M
AIDS; 2010 Jul; 24(11):1765-70. PubMed ID: 20453630
[TBL] [Abstract][Full Text] [Related]
19. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms.
Franceschi S; Dal Maso L; La Vecchia C
Int J Cancer; 1999 Nov; 83(4):481-5. PubMed ID: 10508483
[TBL] [Abstract][Full Text] [Related]
20. Impact of Treatment and Insurance on Socioeconomic Disparities in Survival after Adolescent and Young Adult Hodgkin Lymphoma: A Population-Based Study.
Keegan TH; DeRouen MC; Parsons HM; Clarke CA; Goldberg D; Flowers CR; Glaser SL
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):264-73. PubMed ID: 26826029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
